(Q44392609)

2 December 2017

Role for thromboxane A2 from glomerular thrombi in nephropathy with type 2 diabetic rats (English)

1 reference

2 December 2017

Michiaki Okumura

1

1 reference

2 December 2017

Masahito Imanishi

2

1 reference

2 December 2017

Mikio Okamura

3

1 reference

2 December 2017

Masayuki Hosoi

4

1 reference

2 December 2017

Noriyuki Okada

5

1 reference

2 December 2017

Yoshio Konishi

6

1 reference

2 December 2017

Takashi Morikawa

7

1 reference

2 December 2017

Katsuyuki Miura

8

1 reference

2 December 2017

Tatsuya Nakatani

9

1 reference

2 December 2017

Satoru Fujii

10

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

2 December 2017

1 reference

2 December 2017

72

1 reference

2 December 2017

24

1 reference

2 December 2017

2695-2705

1 reference

Increased urinary excretion of thromboxane B2 and 2,3-dinor-TxB2 in cyclosporin A nephrotoxicity

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900180-2

Thromboxane and prostacyclin differentially regulate murine extracellular matrix gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900180-2

Measurement of renal and non-renal eicosanoid synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900180-2

Thromboxane in the pathogenesis of glomerular injury in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900180-2

Contribution of platelet thromboxane production to enhanced urinary excretion and glomerular production of thromboxane and to the pathogenesis of albuminuria in the streptozotocin-diabetic rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900180-2

Eicosanoids in the pathogenesis of the functional and structural alterations of the kidney in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900180-2

Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900180-2

Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900180-2

Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900180-2

Effects of a selective thromboxane synthetase inhibitor OKY-046 on experimental diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900180-2

Renal production of thromboxane and prostaglandins in a rat model of type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900180-2

Antiplatelet agents in the prevention of diabetic vascular complications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900180-2

Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900180-2

Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900180-2

Thromboxane synthesis and action within the kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900180-2

Prostaglandins and other arachidonic acid metabolites in the kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900180-2

Diabetes mellitus and associated hypertension, vascular disease, and nephropathy. An update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900180-2

Short-term increase in prostaglandin I2 synthesis caused by cicletanine in patients with essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900180-2

Biosynthesis of thromboxane in patients with systemic sclerosis and Raynaud's phenomenon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900180-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0024-3205(03)00180-2

1 reference

2 December 2017

1 reference